Researchers at Mount Sinai launch a new AI platform to match more cancer patients with clinical trials, aiming to expand ...
CDMO conglomerate Almac is pouring $48 million into its eClinical offering via an investment that includes the launch of a new trial coordinator. The “first-in-class” platform will address the top ...
The complex task of managing clinical trial finances is generally accepted as a cost of doing business in the pharmaceutical industry. But today, higher costs and ongoing pressures to shorten study ...
Deloitte’s patient engagement platform suite ConvergeHealth on Feb. 18 launched a new digital platform on Amazon Web Services that connects patients and investigators with clinical research trials.
Digital patient profiles and real-world data enhance oncology trial design, patient recruitment, and reduce trial failure risks. Phesi's platform aligns trial designs with real-world data, minimizing ...
MELBOURNE, Australia, Dec. 11, 2025 /PRNewswire/ -- Neurizon® Therapeutics Limited (ASX: NUZ & NUZOA; OTCQB: NUZTF) ("Neurizon" or "the Company"), a clinical-stage biotech company dedicated to ...
In the Phase 2 Study of TPN-101 in patients with C9orf72-related ALS, TPN-101 showed clinical benefits on key clinical outcome measures, including slow vital capacity and the ALSFRS-R TPN-101 also had ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results